RESUMOA redução do risco de adoecimento entre os contatos domiciliares de casos é um dos alvos das ações de vigilância e controle da hanseníase. Esta pesquisa teve como objetivo avaliar as ações de vigilância de contatos de hanseníase no Município de Igarapé-Açu, Estado do Pará, Brasil, no período de 2004 a 2008. Foi realizado um estudo descritivo, retrospectivo, quantitativo e populacional, com informações geradas pelo Sistema Nacional de Agravos de Notificação (Sinan) e por protocolo de pesquisa próprio, tendo sido identificados 128 casos índices no Sinan municipal, dos quais 53 foram resgatados e entrevistados, ocasião em que 133 contatos foram identificados. Entre os casos índices predominaram o sexo feminino (68%), os maiores de 15 anos de idade (79%) e a forma operacional multibacilar (66%). Entre os contatos, a maioria era do sexo masculino (52,63%), tinha ensino fundamental completo (42,10%), solteiros (42,85%), desempregados (55,63%), com renda familiar inferior a um salário mínimo (60,15%) e com uma cicatriz da vacina BCG-ID (67,67%). A taxa de contatos não avaliados foi de 84 (63,16%), e destes, de acordo com a classificação operacional do caso índice, 56 (66,70%) foram contatos de casos multibacilar; 13 (37,14%) dos casos índices multibacilares foram contatos intradomiciliares de casos de hanseníase anteriores ao período estudado. O município estudado apresentou avaliação precária dos contatos intradomiciliares de acordo com os parâmetros do Ministério da Saúde, o que reforça a necessidade da intensificação das ações de vigilância e controle da hanseníase em municípios endêmicos/hiperendêmicos.

No abstract

Objective: To analyze the severe cases of COVID-19 in Brazil in 2020 and compare those vaccinated and unvaccinated against influenza in invasive ventilation, admission in Intensive Care Unit (ICU) and deaths. Method: Cross-sectional study with public data from the OpenDataSUS platform, regarding confirmed severe cases for COVID-19 in Brazil in the year 2020. Data were analyzed by SPSS, from the chi-square test of independence and binary logistic regression. Results: The population was 472,688 cases and 177,640 deaths, with a lethality of 37.58% in severe cases. The test of independence was highly significant in vaccinated survivors (<0.0001), and regression showed an almost twofold odds ratio for invasive ventilation, ICU admission, and death in unvaccinated cases. Conclusion: We recommend mass influenza vaccination as an adjuvant in combating the COVID-19 pandemic in Brazil.

The COVID-19 reached the pandemic level and in Brazil has already caused 100,477 deaths. This study is a Short Communication about the spatial distribution of deaths by COVID-19 in Brazil, from data from the Coronavirus Brasil platform. It was shown that Rio de Janeiro, São Paulo, Ceará, Pará, and Amazonas present the greatest lethality in Brazil, especially in the metropolitan regions. The distribution of deaths shows that it has already reached all regions of Brazil, with greater impact in some states. It was also possible, from the epidemiological bulletins, to identify that the deaths stand out in men above 60 years of age, with comorbidities such as heart diseases and diabetes.

Objective: To analyze the severe cases of COVID-19 in Brazil in 2020 and compare those vaccinated and unvaccinated against influenza in invasive ventilation, admission in Intensive Care Unit (ICU), and deaths. Method: Cross-sectional study with public data from the OpenDataSUS platform confirmed severe cases for COVID-19 in Brazil in the year 2020. Data were analyzed by SPSS, from the chi-square test of independence and binary logistic regression. Results: The population was 472,688 cases and 177,640 deaths, with lethality of 37.58% in severe cases. The test of independence was highly significant in vaccinated survivors (<0.0001), and regression showed an almost twofold odds ratio for invasive ventilation, ICU admission, and death in unvaccinated cases. Conclusion: We recommend mass influenza vaccination as an adjuvant in combating the COVID-19 pandemic in Brazil.

Background: The COVID-19 pandemic has already affected Brazil dramatically, but the northern region of the country has suffered greater impacts due to regional vulnerability factors. Objective: To describe the factors associated with deaths in hospitalized cancer patients and COVID-19 in the state of Pará, Brazil. Methods: Cross-sectional study with data from epidemiological surveillance of acute and severe respiratory syndromes of hospitalized cases notified from January 1, 2020, to December 31, 2020. Clinical and outcome variables, chi-square test, and Odds ratio were analyzed. Results: 164 cases, lethality represented 94 (57.32%). The mean overall age was 63 years, of survivors was 60 years and of deaths was 66 years. Advanced age was associated with deaths (p-0.039). Male gender was associated with deaths (65.96% - p- 0.006 - OR 2,438 - CI 1,291-4,604). Similarly, the signs and symptoms associated with death were dyspnea (80.85% - p- 0.028 - OR 2,203 - CI 1,080-4,491), respiratory distress (76.60% - p- 0.003 - OR 2,756 - CI 1,410-5,387), O2 saturation <95% represented almost four times to the chances of death (68.09% - p-<0.001 - OR 3,398 - CI 1,798-6,494). Comorbidities were not associated with deaths, however, Immunodeficiency/Immunodepression represented the most frequent in the cases (22.56%), followed by Chronic Cardiovascular Disease (21.95%) and Diabetes Mellitus (18.90%). ICU admission was associated with deaths with the highest odds ratio of the analysis almost five times (42.55% - p- <0.001 - OR 4,444 - CI 2,028-9,739). Conclusion: In this study, we showed that the lethality was higher than in other studies of hospitalized cancer patients with COVID-19, as well as higher than the overall lethality of COVID-19 among hospitalized patients. The factors associated with deaths are similar to those in the literature, except that immunodeficiency is a specific condition in cancer patients and is associated with an unfavorable outcome.

OBJETIVO: Validar um instrumento para controle de cura sifilítica em puérperas e seus RN, após alta da maternidade. MÉTODO: Design Science Research, com juízes escolhidos pela técnica “bola de neve”. Seguiram-se as etapas de: levantamento bibliográfico; elaboração da tecnologia; validação pelos especialistas, avaliando a tecnologia através de um instrumento de coleta de dados – com uma escala de Likert e espaços para justificativas abertas. A análise dos dados foi feita pelo cálculo do Índice de Validade de Conteúdo (IVC) para cada item para o instrumento. O contato entre pesquisador e juízes se deu via e-mail. RESULTADOS: Participaram da avaliação 5 juízes especialistas. Todos os itens foram considerados relevantes (IVC≥ 0,80), gerando, para o instrumento como um todo, um IVC= 1. Os itens da seção “Identificação do(a) usuário(a)” foram incrementados; na seção “Informações diagnósticas e terapêuticas”, julgou-se pertinente manter campo para registro do teste não-treponêmico, excluindo teste treponêmico. CONCLUSÃO: O instrumento foi validado, apresentando confiabilidade de implementação. A tecnologia será capaz de auxiliar profissionais da atenção primária a conduzir o controle de cura sifilítica de RN e puérperas; e poderá fortificar a comunicação entre os níveis de atenção à saúde.Palavras-chave: Estudos de validação; Sífilis; Cuidados de seguimento; Prática em saúde pública.

In the absence of an analysis of deaths at home from an epidemiological perspective, this study aims to analyze and describe the epidemiological profile of deaths at home assessed by the Death Ceremony Service (DCS) during the SARS-CoV-2 pandemic in the metropolitan region of the Brazilian Amazon, Belém do Pará. A descriptive, quantitative, secondary-based study based on the databases of the Mortality Information System (SIM), referring to the deaths that occurred from March 1 to March 27 June 2020. The variables worked were related to the profile and the causes in the death certificate. The causes of home deaths in 2019 were used to compare with 2020. In the indicated period, 1,203 deaths occurred, an increase of 454% in relation to 2019. The male gender (57.30%), the age group of 60+ (80.80%) and brown race (77.70%) were the most frequent. The main cause of death Acute myocardial infarction (15.05%) followed by COVID-19 (10.29%). During the pandemic, the majority of home deaths were not directly caused by COVID-19, however, they were influenced by it due to the need for social isolation, with the impossibility of obtaining the proper diagnosis or proper treatment, due to the impossibility of on-site care or lack of immediate response.